Summary
The effect of the new glutamate uptake inhibitor, L-trans-pyrrolidine-2,4-dicarboxylic acid (L-trans-PDC), on the electrically evoked release or, rather, overflow of endogenous glutamate in superfusates from rat cortical slices was compared with that of dihydrokainate. In the absence of these presumed uptake inhibitors, electrical stimulation for 4 min at 1 Hz did not elicit a measurable glutamate overflow over baseline at all. Basal overflow increased concentration-dependently in the presence of 10–100 μM L-trans-PDC, about 5-fold at 100 μM. Also, electrical stimulation caused increases of glutamate overflow over basal levels progressive with increasing concentrations of trans-PDC; a stimulated overflow corresponding to about 50% of basal overflow was obtained at 100 μM. Basal as well as evoked release in the presence of dihydrokainate did not exceed ca. 60% of that obtained with 100 μM L-trans-PDC. In synaptosomes, L-trans-PDC much more than dihydrokainate caused a transient increase of spontaneous glutamate release which was diminished in the absence of Na+, indicating that it is transported into the cytoplasm by the glutamate carrier and induces some efflux of the amino acid from this compartment. Moreover, trans-PDC caused a weak to moderate inhibition of K+-evoked glutamate release from synaptosomes at 10–300 μM, without obvious concentration-dependence.
Glutamate overflow elicited from rat cortical slices by electrical field stimulation at 1 Hz was Ca2+-dependent to about 80%. Tetrodotoxin (0.3 μM) reduced it by about 90%. Lowering the temperature from 37°C to 22°C increased the ratio between evoked and basal overflow.
As an application for L-trans-PDC as a glutamate uptake inhibitor in release studies, the regulation of glutamate release by GABAB receptors was investigated. At 1 Hz, (−)-baclofen reduced evoked glutamate overflow at and above 3 μM by maximally 40% at 30 μM. This maximal effect was not increased when higher or lower stimulation frequencies were used nor when the Ca2+ concentration in the medium was increased or lowered, nor when the slices were prepared from other brain areas (hippocampus or striatum). The GABA uptake inhibitor, SK&F 89976, had no significant effect on evoked glutamate overflow, and the potent GABAB antagonist, CGP 55845, induced only a small increase, indicating that tonic inhibition of glutamate by GABA via GABAB receptors was not marked. On the other hand, the GABAB antagonist was able to prevent the inhibitory effect of (−)-baclofen when applied before it and to abolish it when applied afterwards. The conclusion is that L-trans-PDC is a useful tool in glutamate release studies in brain slices for many purposes, with the reservation that its inhibitory effect on evoked glutamate release in synaptosomes is not yet understood.
Similar content being viewed by others
References
Bonanno G, Raiteri M (1992) Functional evidence for multiple γ-aminobutyric acidB receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther 262:114–118
Bridges RJ, Stanley MS, Anderson MW, Cotman CW, Chamberlin AR (1991) Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 34:717–725
Brodin L, Tossman U, Ohta Y, Ungerstedt U, Grillner S (1988) The effect of an uptake inhibitor (dihydrokainate) on endogenous excitatory amino acids in the lamprey spinal cord as revealed by microdialysis. Brain Res 458:166–169
Burke SP, Nadler VJ (1988) Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen. J Neurochem 51:1541–1551
Clements JD, Lester RAJ, Tong G, Jahr, GE, Westbrook GL (1992) The time course of glutamate in the synaptic cleft. Science 258: 1498–1501
Connick JH, Stone TW (1988) Excitatory amino acid antagonists and endogenous aspartate and glutamate release from rat hippocampal slices. Br J Pharmacol 93:863–867
Farnebo LO (1971) Release of monoamines evoked by field stimulation. Studies on some ionic and metabolic requirements. Acta Physiol Scand 371 [Suppl]:19–27
Ferkany J, Coyle JT (1986) Heterogeneity of sodium-dependent excitatory amino acid uptake mechanisms in rat brain. J Neurosci Res 16:491–503
Froestl W, Mickel SJ, von Sprecher G, Bittiger H, Olpe H-R (1992) Chemistry of new GABAB antagonists. Pharmacol Comm 2:52–56
Garthwaite J (1985) Cellular uptake disguises action of L-glutamate on N-methyl-D-aspartate receptors. Br J Pharmacol 85:297–307
Johnston GA, Curtis DR, Davies J, McCulloch RM (1974) Spinal interneurone excitation by conformationally restricted analogues of L-glutamic acid. Nature 248:804–805
Johnston GA, Kennedy SM, Twitchin B (1979) Action of the neurotoxin kainic acid on high-affinity uptake of L-glutamic acid in rat brain slices. J Neurochem 32:121–127
Johnston GAR, Lodge D, Bornstein JC, Curtis DR (1980a) Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stercoisomers of threo-3-hydroxyaspartate. J Neurochem 34:241–243
Johnston GAR, Hailstone MH, Freeman CG (1980b) Baclofen: stereoselective inhibition of excitant amino acid release. J Pharm Pharmacol 32:230–231
Kato K, Goto M, Fukuda H (1982) Baclofen: inhibition of the release of L[3H]glutamate and L[3H]aspartate from rat whole brain synaptosomes. Gen Pharmacol 13:445–447
Littman L, Munir M, Flagg SD, Robinson MB (1992) Multiple mechanisms for inhibition of excitatory amino acid receptors coupled to phosphoinositide hydrolysis. J Neurochem 59:1893–1904
Lodge D, Curtis DR, Johnston GA, Bornstein JC (1980) In vivo inactivation of quisqualate: studies in the cat spinal cord. Brain Res 182:491–495
Nicholls D, Attwell D (1990) The release and uptake of excitatory amino acids. TIPS 11:462–467
Olverman HJ, Jones AW, Mewett KN, Watkins JC (1988) Structure/activity relations of N-methyl-D-aspartate receptors ligands as studied by their inhibition of [3H]D-2-amino-5-phosphonopentanoic acid binding in rat brain membranes. Neuroscience 26:17–31
Potashner SJ (1979) Baclofen: Effects on amino acid release and metabolism in slices of guinea-pig cerebral cortex. J Neurochem 32:103–109
Robinson MB, Hunter-Ensor M, Sinor J (1991) Pharmacologically distinct sodium-dependent L-[3H]glutamate transport processes in rat brain. Brain Res 544:196–202
Sarantis M, Ballerini L, Edwards M, Miller B, Silver A, Attwell D (1993) Effects of the glutamate uptake blocker L-trans-PDC on isolated salamander retinal glia and isolated rat neurones. J Physiol (Lond) 459:246 (abstract)
Waldmeier PC, Wicki P, Feldtrauer JJ, Baumann PA (1988) The of the release of endogenous GABA from rat brain slices by liquid chromatography with electrochemical detection. Naunyn-Schmiedeberg's Arch Pharmacol 337:284–288
Waldmeier PC, Hertz C, Wicki P, Grunenwald C, Baumann PA (1993) Autoreceptor-mediated regulation of GABA release: role of uptake inhibition and effects of novel GABAB antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 347:514–520
Yunger LM, Fowler PJ, Zarevics P, Setler PE (1984) Novel inhibitors of γ-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. J Pharmacol Exp Ther 228:109–115
Zhu X-Z, Chuang D-M (1987) Modulation of calcium uptake and D-aspartate release by GABAB receptors in cultured cerebellar granule cells. Eur J Pharmacol 141:401–408
Author information
Authors and Affiliations
Additional information
Correspondence to: P. C. Waldmeier at the above address
Rights and permissions
About this article
Cite this article
Waldmeier, P.C., Wicki, P. & Feldtrauer, JJ. Release of endogenous glutamate from rat cortical slices in presence of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid. Naunyn-Schmiedeberg's Arch Pharmacol 348, 478–485 (1993). https://doi.org/10.1007/BF00173206
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173206